Related Experiment Videos
Haemostatic factors in human aortic intima.
Lancet (London, England)
|May 30, 1981
Summary
Fibrin accumulation in atherosclerotic plaques may drive lesion development by binding lipids and sequestering clotting factors. This suggests a self-amplifying process within the intima, contributing to atherosclerosis progression.
Area of Science:
- Cardiovascular Biology
- Thrombosis and Hemostasis
- Atherosclerosis Research
Background:
- Lipid accumulation in atherosclerotic plaques correlates with high fibrin concentrations.
- Fibrin may play a crucial role in the development of atherosclerotic lesions.
- The origin of fibrin within lesions (mural thrombus vs. in situ clotting) remains unclear.
Purpose of the Study:
- To investigate the role of fibrin and clotting factors in atherosclerotic plaque development.
- To determine the source of fibrin within human aortic intima and lesions.
- To elucidate the mechanisms of fibrin-mediated lipid and clotting factor accumulation.
Main Methods:
- Immunoelectrophoresis was employed to quantify fibrinogen and clotting system components.
- Analysis was performed on human aortic intima, atherosclerotic lesions, and mural thrombi.
- Concentrations of prothrombin, antithrombin III, alpha 2-macroglobulin, and factor-VIII-related antigen were measured.
Main Results:
- Prothrombin concentration was elevated in plaque centers compared to normal intima, while thrombin inhibitors decreased.
- Mural thrombi showed preferential sequestration of fibrinogen and prothrombin.
- Factor-VIII-related antigen distribution was variable, with highest concentrations in endothelium-denuded deep lesion layers.
Conclusions:
- Findings support the conversion of fibrinogen to fibrin within atherosclerotic lesions.
- Accumulated fibrin appears to bind low-density lipoprotein and sequester clotting factors.
- This process may create a self-amplifying system contributing to atherosclerosis progression.